Contrast induced nephropathy: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Contrast induced nephropathy}} | {{Contrast induced nephropathy}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{MM}} | ||
{{SK}} Contrast agent-associated nephrotoxicity; contrast associated nephrotoxicity; contrast induced ATN; contrast induced acute tubular necrosis; CAN; CIAKI; CIN; contrast-induced acute kidney injury | |||
== [[Contrast induced nephropathy overview|Overview]] == | == [[Contrast induced nephropathy overview|Overview]] == | ||
== [[Contrast induced nephropathy definition|Definition]] == | |||
== [[Contrast induced nephropathy historical perspective|Historical Perspective]] == | == [[Contrast induced nephropathy historical perspective|Historical Perspective]] == | ||
| Line 11: | Line 13: | ||
== [[Contrast induced nephropathy pathophysiology|Pathophysiology]] == | == [[Contrast induced nephropathy pathophysiology|Pathophysiology]] == | ||
== [[Contrast induced nephropathy differential diagnosis|Differentiating Contrast | == [[Contrast induced nephropathy differential diagnosis|Differentiating Contrast Induced Nephropathy from other Diseases]] == | ||
== [[Contrast induced nephropathy epidemiology and demographics|Epidemiology and Demographics]] == | == [[Contrast induced nephropathy epidemiology and demographics|Epidemiology and Demographics]] == | ||
| Line 17: | Line 19: | ||
== [[Contrast induced nephropathy risk factors|Risk Factors]] == | == [[Contrast induced nephropathy risk factors|Risk Factors]] == | ||
== [[Contrast induced nephropathy natural history|Natural History, Complications and Prognosis]] == | == [[Contrast induced nephropathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | ||
== Diagnosis == | == Diagnosis == | ||
[[Contrast induced nephropathy history and symptoms|History and Symptoms]] | [[Contrast induced nephropathy physical examination|Physical Examination]] | [[Contrast induced nephropathy laboratory | [[Contrast induced nephropathy history and symptoms|History and Symptoms]] | [[Contrast induced nephropathy physical examination|Physical Examination]] | [[Contrast induced nephropathy laboratory findings|Laboratory Findings]] | [[Contrast induced nephropathy CT|CT]] | [[Contrast induced nephropathy ultrasound|Ultrasound]] | [[Contrast induced nephropathy other imaging findings|Other Imaging Findings]] | [[Contrast induced nephropathy other diagnostic studies|Other Diagnostic Studies]] | ||
== Treatment == | == Treatment == | ||
Latest revision as of 15:18, 14 September 2015
|
Contrast Induced Nephropathy Microchapters |
|
Differentiating Contrast induced nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Contrast induced nephropathy On the Web |
|
American Roentgen Ray Society Images of Contrast induced nephropathy |
|
Directions to Hospitals Treating Contrast induced nephropathy |
|
Risk calculators and risk factors for Contrast induced nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Synonyms and keywords: Contrast agent-associated nephrotoxicity; contrast associated nephrotoxicity; contrast induced ATN; contrast induced acute tubular necrosis; CAN; CIAKI; CIN; contrast-induced acute kidney injury
Overview
Definition
Historical Perspective
Pathophysiology
Differentiating Contrast Induced Nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies